Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)

NCT00983606 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT00983606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00983606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Lead sponsor
MedImmune LLC
Phase
Observational
Overall status
Completed
Start date
September 30, 2009
Completion date
July 31, 2011
Enrollment
3,000 (estimated)
Sites
222

Conditions

As the registry lists them; a condition with its own page is linked.

healthy